Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seda Eminaga

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Physiological Genomics|February 3, 2011
Age-related autocrine diabetogenic effects of transgenic resistin in spontaneously hypertensive rats: gene expression profile analysisMichal Pravenec, Václav Zídek, Vladimír Landa, et al.
JCI Insight|May 31, 2016
Molecular profiling of dilated cardiomyopathy that progresses to heart failureMichael A Burke, Stephen Chang, Hiroko Wakimoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2010
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathyTetsuo Konno, Dan Chen, Libin Wang, et al.
EMBO Molecular Medicine|July 10, 2025
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2Hyun-Ju Cho, Joy Smith, Christopher H Switzer, et al.
The Journal of Clinical Investigation|September 3, 2010
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-βPolakit Teekakirikul, Seda Eminaga, Okan Toka, et al.
The Journal of Clinical Investigation|February 11, 2014
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathyDanos C Christodoulou, Hiroko Wakimoto, Kenji Onoue, et al.
JCI Insight|November 3, 2018
Inhibition of profibrotic microRNA-21 affects platelets and their releasateTemo Barwari, Seda Eminaga, Ursula Mayr, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Physiological Genomics|February 3, 2011
Age-related autocrine diabetogenic effects of transgenic resistin in spontaneously hypertensive rats: gene expression profile analysisMichal Pravenec, Václav Zídek, Vladimír Landa, et al.
JCI Insight|May 31, 2016
Molecular profiling of dilated cardiomyopathy that progresses to heart failureMichael A Burke, Stephen Chang, Hiroko Wakimoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2010
Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathyTetsuo Konno, Dan Chen, Libin Wang, et al.
EMBO Molecular Medicine|July 10, 2025
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2Hyun-Ju Cho, Joy Smith, Christopher H Switzer, et al.
The Journal of Clinical Investigation|September 3, 2010
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-βPolakit Teekakirikul, Seda Eminaga, Okan Toka, et al.
The Journal of Clinical Investigation|February 11, 2014
5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathyDanos C Christodoulou, Hiroko Wakimoto, Kenji Onoue, et al.
JCI Insight|November 3, 2018
Inhibition of profibrotic microRNA-21 affects platelets and their releasateTemo Barwari, Seda Eminaga, Ursula Mayr, et al.
Pageof 2